perhexiline and dextrorphan

perhexiline has been researched along with dextrorphan in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bochner, F; Kerry, NL; Mikus, G; Somogyi, AA1
Coller, JK; Davies, BJ; Gillis, D; Horowitz, JD; James, HM; Morris, RG; Sallustio, BC; Somogyi, AA1

Trials

1 trial(s) available for perhexiline and dextrorphan

ArticleYear
Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexiline.
    British journal of clinical pharmacology, 2004, Volume: 57, Issue:4

    Topics: Aged; Angina Pectoris; Cardiovascular Agents; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dextrorphan; Female; Humans; Male; Perhexiline

2004

Other Studies

1 other study(ies) available for perhexiline and dextrorphan

ArticleYear
The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes.
    British journal of clinical pharmacology, 1994, Volume: 38, Issue:3

    Topics: Autoantibodies; Binding, Competitive; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Dextromethorphan; Dextropropoxyphene; Dextrorphan; Humans; In Vitro Techniques; Methadone; Methylation; Microsomes, Liver; Mixed Function Oxygenases; Oxidation-Reduction; Perhexiline; Phenotype; Quinidine

1994